Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump

Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.Read more...

Related Posts

Nvidia, Broadcom, Costco, Walgreens: Stocks to watch today

Mar 7, 2025  0

Trump says tariffs will help car companies. Here's why ...

Feb 26, 2025  0

The 5 cities with the best budgeters in America — and t...

Feb 11, 2025  0

Comments

Name

Email

Comment

Post Comment